You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Gd Searle Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GD SEARLE, and what generic and branded alternatives to GD SEARLE drugs are available?

GD SEARLE has twenty-eight approved drugs.

Summary for Gd Searle

US Patents:	0
Tradenames:	26
Ingredients:	17
NDAs:	28

Drugs and US Patents for Gd Searle

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gd Searle Llc	POTASSIUM CHLORIDE	potassium chloride	INJECTABLE;INJECTION	086219-003	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Gd Searle Llc	AMINOPHYLLIN	aminophylline	INJECTABLE;INJECTION	087243-001	May 24, 1982		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Gd Searle Llc	AMINOPHYLLIN	aminophylline	TABLET;ORAL	002386-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Gd Searle	BEXTRA	valdecoxib	TABLET;ORAL	021341-003	Nov 16, 2001		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Gd Searle Llc	TATUM-T	copper	INTRAUTERINE DEVICE;INTRAUTERINE	018205-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Gd Searle Llc	POTASSIUM CHLORIDE	potassium chloride	INJECTABLE;INJECTION	086220-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Gd Searle

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Gd Searle Llc	TATUM-T	copper	INTRAUTERINE DEVICE;INTRAUTERINE	018205-001	Approved Prior to Jan 1, 1982	3,563,235	⤷ Sign Up
Gd Searle Llc	CU-7	copper	INTRAUTERINE DEVICE;INTRAUTERINE	017408-001	Approved Prior to Jan 1, 1982	3,803,308	⤷ Sign Up
Gd Searle Llc	CU-7	copper	INTRAUTERINE DEVICE;INTRAUTERINE	017408-001	Approved Prior to Jan 1, 1982	4,040,417	⤷ Sign Up
Gd Searle Llc	TATUM-T	copper	INTRAUTERINE DEVICE;INTRAUTERINE	018205-001	Approved Prior to Jan 1, 1982	4,040,417	⤷ Sign Up
Gd Searle	BEXTRA	valdecoxib	TABLET;ORAL	021341-002	Nov 16, 2001	5,633,272	⤷ Sign Up
Gd Searle Llc	CU-7	copper	INTRAUTERINE DEVICE;INTRAUTERINE	017408-001	Approved Prior to Jan 1, 1982	RE28399	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.